Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial.
- Resource Type
- Article
- Source
- Lancet Respiratory Medicine; Jul2023, Vol. 11 Issue 7, p613-623, 11p
- Subject
COVID-19 vaccines BOOSTER vaccines IMMUNE response SARS-CoV-2 SCIENCE projects - Language
- ISSN
- 22132600